Table 3. Antibiotic disk diffusion test and quantification of the resistant mutant subpopulations of the 38 P. aeruginosa CF isolates.
Isolate | MRS genesa | Ceftazidime | Ciprofloxacin | Imipenem | Meropenem | Tobramycin | |||||
DD | RMS | DD | RMS | DD | RMS | DD | RMS | DD | RMS | ||
1a | - | S | +++ | S | ++ | S | +++ | S | +++ | S | ++ |
1b | - | S | +++ | I | ++ | S | +++ | S | +++ | R | * |
1c | + | S | ++ | S | - | S | - | S | ++ | S | - |
2a | - | R | * | R | * | S | +++ | S | +++ | S | +++ |
2b | + | S | + | S | - | S | - | S | + | S | - |
3a | - | I | ++ | I | - | S | +++ | S | +++ | I | +++ |
3b | - | R | * | I | ++ | I | +++ | S | +++ | I | +++ |
3c | - | S | +++ | S | +++ | S | +++ | S | +++ | S | ++ |
4a | + | S | - | S | - | S | - | S | - | S | - |
4b | + | S | - | S | - | S | - | S | - | S | - |
5a | - | S | - | R | * | S | ++ | S | +++ | S | + |
6a | + | S | - | S | - | S | - | S | - | S | - |
7a | + | S | - | I | - | S | - | S | - | S | - |
8a | + | S | - | R | * | S | +++ | S | +++ | S | - |
9a | - | S | ++ | S | +++ | S | +++ | S | +++ | S | +++ |
10a | - | S | ++ | S | ++ | S | +++ | S | - | S | +++ |
11a | + | S | - | S | - | S | - | S | - | R | * |
12a | + | S | - | S | - | S | - | S | - | S | - |
13a | + | S | - | R | * | S | - | S | - | R | * |
14a | + | S | - | S | - | S | - | S | - | S | - |
15a | + | S | - | S | - | S | - | S | - | S | - |
16a | + | S | - | S | - | S | - | S | - | S | - |
17a | + | S | - | I | - | R | * | I | - | S | - |
17b | - | S | - | S | - | I | +++ | S | ++ | S | + |
18a | + | S | - | S | - | S | - | S | - | S | - |
18b | + | S | - | R | * | S | - | S | - | S | - |
18c | + | S | - | S | - | S | - | S | - | S | - |
18d | - | S | +++ | R | * | R | * | S | +++ | R | ++ |
19a | - | R | * | R | * | R | * | R | * | R | * |
20a | + | S | - | S | - | S | - | S | - | S | - |
20b | - | S | +++ | R | * | R | * | S | +++ | S | +++ |
21a | - | S | +++ | R | * | S | ++ | S | +++ | S | +++ |
21b | - | S | +++ | R | * | S | +++ | S | +++ | S | +++ |
22a | - | S | - | S | - | S | ++ | S | +++ | S | +++ |
23a | + | S | - | S | - | S | - | S | ++ | S | - |
24a | + | S | - | S | - | S | - | S | - | S | - |
25a | + | S | - | S | - | S | - | S | - | S | - |
26a | + | S | - | S | - | S | - | S | - | S | - |
MRS genes was considered positive (+) when the sequences of mutS and mutL genes were wild type and negative (−) when were mutated.
DD, diffusion diameter zone; RMS, resistant mutant subpopulation: +<10 mutants; ++ 10 to 100 mutants; +++ >100 mutants.
Zone diameter interpretative criteria was according to CLSI: S, susceptible; I, intermediate resistance; R, resistant.
*lack of diffusion zone that prevents the resistant mutant subpopulation to be quantified.